Mark A. Reynolds

Papers

Total Citations

235

H-Index

About

Mark A. Reynolds is a leading figure in stroke diagnostics, best known for his pioneering work on early biomarkers for acute ischemic stroke. His landmark 2003 paper, “Early Biomarkers of Stroke,” with over 235 citations, addressed a critical gap in emergency medicine: the lack of rapid, reliable blood-based assays to complement CT scanning, which is notoriously insensitive for ischemic events. Reynolds’ research has been instrumental in identifying molecular signatures that enable faster, more accurate diagnosis, directly impacting clinical decision-making in the critical window for treatment. His contributions have advanced the field of neurovascular biomarker discovery, bridging the gap between bench research and bedside application. Beyond this seminal work, Reynolds has continued to explore novel diagnostic and prognostic tools for cerebrovascular disease, earning recognition from neurology and emergency medicine communities. For students and researchers, his work exemplifies how targeted biomarker research can transform acute care, offering a compelling model for translating molecular insights into life-saving clinical practices.